
Shenluo Medical
神络医疗
Shenluo Medical
Biotech/Healthcare
Founded in December 2018, Hangzhou Shenluo Medical Technology develops innovative neuromodulation technologies to provide more advanced and effective treatments for patients with pain, epilepsy, heart failure, and other conditions, improving their quality of life. Its current pipeline includes…
Latest round: Series C (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.